Yo-yo dieting takes on a new shape in the age of Ozempic
Oliver Hamer, Edge Hill University/The Conversation Continue Reading Category: Obesity , Illnesses and conditions , Body and Mind , Refractor: Science & Health Tags: GLP-1 receptor agonists , Weight…
Read the full articleYou might also wanna read
GLP-1 and weight-loss drugs: How fast-track health solutions are reshaping FMCG
GLP-1 weight-loss drugs are reshaping FMCG as health, body control, and self-optimization trends redefine consumer behaviour across Europe.
New GLP-1 Drug Promotes Weight Loss in Obesity
A new strategy for delivering GLP-1 drugs to patients with obesity or who were overweight resulted in up to an 11 percent reduction in body
How new weight-loss drugs may offer hope for curbing addiction
Drugmakers are racing to develop ever newer versions of the GLP-1 drugs, and regulators around the world are approving them at an equally ra
GLP-1 Receptor Agonists Show Promise Against Obesity Related Cancer
The post GLP-1 Receptor Agonists Show Promise Against Obesity Related Cancer appeared first on European Medical Journal .
Study: GLP-1 Weight Loss Drugs Linked to Decline in Daily Physical Activity
A new study study using NIH Fitbit data reveals that GLP-1 weight loss drugs trigger a significant drop in muscle-preserving physical activi
neurosciencenews.com·1mo agoCan New Drugs Help Millions of Americans with Obesity?
Can New Drugs Help Millions of Americans with Obesity? Olivia Farrar Mon, 09/30/2024 - 12:01 More than 100 million Americans struggle with o
Comments
Sign in to join the conversation.
No comments yet. Be the first.